Factors Associated With Trial Completion and Adherence in App-Based N-of-1 Trials: Protocol for a Randomized Trial Evaluating Study Duration, Notification Level, and Meaningful Eng...

by Bobe, Jason R, Buros, Jacqueline, Golden, Eddye, Johnson, Matthew, Jones, Michael, Percha, Bethany, Viglizzo, Ryan, Zimmerman, Noah
Published 2020-01-01

2048 The hypertrophic cardiomyopathy phenotype revisited with cardiovasculara magnetic resonance

by Manning Warren J, Lesser John R, Udelson James E, Gibson C Michael, Buros Jacqueline, Harrigan Caitlin, Appelbaum Evan, Maron Martin S, Maron Barry J
Published 2008-10-01

233 Evidence that post-contrast delayed enhancement identified by cardiovascular magnetic resonance is an arrhythmogenic substrate in hypertrophic cardiomyopathy

by Udelson James E, Hanna Constance A, Lesser John R, Gibson C Michael, Buros Jacqueline L, Harrigan Caitlin J, Maron Barry J, Appelbaum Evan, Adabag A Selcuk, Manning Warren J, Maron Martin S
Published 2008-10-01

Is the 12-lead electrocardiogram of value in the prognostic assessment of patients with hypertrophic cardiomyopathy?

by Udelson James E, Haas Tammy S, Lesser John R, Gibson C Michael R, Biller Leah, Buros Jacqueline L, Harrigan Caitlin, Appelbaum Evan, Rowin Ethan J, Manning Warren J, Maron Barry J, Maron Martin S
Published 2010-01-01